Source comparison
TB-500 for Tennis Elbow: Clinical Applications vs Research Evidence
Mechanism Upregulates actin polymerisation, promotes VEGF-driven angiogenesis, modulates NF-κB inflammatory signaling Same biological pathways, but human tendon healing timelines (12–16 weeks) exceed most study durations TB-500 addresses the biological constra
This comparison does not assign a generated winner or score.
- Mechanism
- Upregulates actin polymerisation, promotes VEGF-driven angiogenesis, modulates NF-κB inflammatory signaling
- Same biological pathways, but human tendon healing timelines (12–16 weeks) exceed most study durations
- TB-500 addresses the biological constraint in chronic tendinopathy. Collagen disorganisation and vascular insufficiency. But requires structured rehab to translate cellular changes into functional improvement
- Dosing Evidence
- Animal models: 2–10mg subcutaneous, 2x/week for 4–6 weeks shows increased collagen organisation and tensile strength
- Human protocols extrapolated from veterinary and athletic use. No Phase III trials for tendon pathology exist
- Dosing is informed but not FDA-validated; most protocols use conservative ranges (2.5–5mg) to balance efficacy with cost and minimise unknown risks
- Outcome Metrics
- Histology (collagen alignment, capillary density), biomechanical testing (failure load, elastic modulus)
- Patient-reported pain (VAS), grip strength, return to activity timelines
- Lab metrics don't always correlate with functional recovery. A tendon can show improved histology but remain symptomatic if motor control or eccentric loading capacity isn't addressed concurrently
- Timeframe
- Detectable tissue changes at 2–4 weeks in animal models; peak benefit at 8–12 weeks
- Human patients report subjective improvement at 3–6 weeks; objective strength gains lag by 8–12 weeks
- Peptide therapy front-loads repair biology, but functional gains require time under load. Expecting pain-free activity at week 4 is unrealistic
- Adjunct Therapy
- Most studies combine TB-500 with controlled mechanical loading (eccentric exercises, progressive resistance)
- Peptide-only protocols without rehab show limited durability. Pain returns when activity resumes
- TB-500 is a biological accelerant, not a standalone fix; outcomes depend entirely on concurrent physical therapy quality